Background: In -thalassemia, there are varying degrees of ineffective haematopoiesis, intermittent haemolysis and iron overload. Excess iron is deposited in organs such as the heart, the liver, the endocrine glands and the lungs.
-thalassemia major is characterised by abnormal haemoglobin (Hb) synthesis, which results in decreased oxygen delivery to the tissues, ineffective erythropoiesis and iron overload (Ramzi et al., 2004) . To improve the oxygen-carrying capacity of the blood, patients receive regular transfusions (Ramzi, 2009) .
Many of the complications of -thalassemia major result from iron deposition in the heart, endocrine organs and lungs (Carnelli et al., 2003) . Although pulmonary dysfunction is not the most significant clinical manifestation of thalassemia, a certain reduction of pulmonary values has been reported to occur in most subjects with -thalassemia (Sritippayawan et al., 2005) .
Different types of pulmonary function abnormalities have been described in -thalassemia major patients. A restrictive pattern has been reported as the most frequent abnormality in the pulmonary function test in thalassemia patients in the literature, especially in adults (Abu-Ekteish et al., 2007) . However, airway obstruction, diffusion impairment or small-airway disease were also reported (Alyasin et al., 2011; Bourli et al., 2012; Boddu et al., 2015) .
The precise aetiology of the pulmonary dysfunction remains unknown. Several pathological mechanisms for pulmonary dysfunction in thalassemia have been investigated, such as lung fibrosis and/or interstitial oedema related to iron overload (Eidani et al., 2009) , aberrant alveolar growth due to chronic hypoxemic status, cardiac damage due to hemosiderosis, (Khaled et al., 2004) , impending diaphragm elevation by enlarged liver (Jamal et al., 2005) or micro-embolisation of the pulmonary arteries due to acknowledged hypercoagulable status in thalassemia major (Sonakul & Fucharoen, 1992) .
This study aimed to evaluate the pulmonary functions in asymptomatic beta thalassemic children on regular transfusion therapy and their relation to iron overload.
METHODS

Subjects and study design
This case-control study included 50 children with -thalassemia major on a regular monthly or bimonthly blood transfusion programme to maintain Hb at around 9 g dL −1 . They were enrolled from the haematology outpatient clinic, Minia University Children Hospital, from the period of January 2016 till May 2016. A total of 50 gender-and age-matched apparently healthy children were enrolled as the control group. We excluded from this study any children suffering from: previous or current history of asthma or chronic respiratory disease, recent (upper or lower) respiratory tract infection, cardiac diseases and any musculoskeletal abnormality.
All thalassemic children were receiving iron chelation therapy. They were treated with either: (i) desferrioxamine (DFO), 40 mg kg −1 day −1 , subcutaneous infusion 6 days per week at 8-12 h per day at night using a Desferal pump for 6 months, (ii) deferasirox (DFX) 30 mg kg −1 day −1 in a single oral dose on empty stomach daily for 6 months or (iii) deferiprone (DFP) 75 mg kg −1 day −1 in three divided oral doses daily for 6 months. The study complied with the Declaration of Helsinki principles. It was explained in detail to the parents or legal guardians of the participating children, and written consent was obtained from them. The protocol of the study was approved by the Institutional Research Committee of the Faculty of Medicine, Minia University.
Methods
Pulmonary function tests were scheduled on the day of blood transfusion. Hb, chest radiograph and oxygen concentration were taken pre-transfusion at the same day set for blood transfusion. Serum ferritin was derived by calculating the average measurement over the last 2 years for each thalassemic child. Serum ferritin levels were taken from the child's follow-up file.
Pulmonary function tests
Spirometry was measured by a dry rolling-seal spirometer (ZAN 300, Germany). The best of at least three technically acceptable values for forced expiratory volume at one second (FEV1), forced vital capacity (FVC), peak expiratory flow (PEFR), forced mid-expiratory flow (FEF25-7) and flow-volume curves were selected. Lung volumes [functional residual capacity (FRC), residual volume (RV) and total lung capacity (TLC)] were measured using the helium dilution test (ZAN 300 Germany). All parameters were expressed in percentages corrected for body temperature, atmospheric pressure and saturation with water vapour (BTPS). Restrictive ventilatory deficit was defined as a reduction of TLC less than 80%. Restrictive pulmonary deficits were classified by TLC % as mild (70-79%), moderate (60-69%) and severe (<60%) (American Thoracic Society, 1991) .
Diffusion [transfer factor for carbon monoxide (TLCO) or diffusing capacity of carbon monoxide (DLCO) and transfer coefficient (KCO)] was measured by the single-breath technique using the ZAN 300 (Germany), and the values were corrected for Hb concentration. The gas mixture used to estimate TLCO contained 0·3% methane (CH 4 ), 0·3% acetylene (C 2 H 2 ), 0·3% carbon monoxide (CO), 21% oxygen (O 2 ) and the balance nitrogen (N 2 ). Diffusion impairment was defined as a reduction in DLCO to less than 80%. Diffusion deficits were classified by DLCO% as mild (60-79%), moderate (40-69%) and severe (<40%) (Miller et al., 2005) . Oxygen saturation (SpO 2 ) was monitored by pulse oximetry (CMS50DL, China).
Statistical analysis
All statistical procedures were performed using the Statistical Package for Social Sciences (SPSS) Windows Version 17·0 (spss Inc., Chicago, IL, USA). Data were summarised by the mean ± SD or number (percentage). For the comparison of means, unpaired, independent sample t-test was used. For the comparison of qualitative variables, a 2 test was used. For comparison between more than two groups, the anova test was used. The Spearman correlation coefficient was used to rank different variables as either positive or inverse. The degrees of association between pulmonary function tests (PFTs) and other parameters, including serum ferritin levels, and pre-transfusion Hb were determined using the Spearman/Pearson correlation test. The variables were investigated using visual histograms and probability plots. A P-value <0·05 was considered statistically significant.
RESULTS
In this study, the thalassemic children included 31 males (62%) and 19 females (38%), with a mean age of 13·2 ± 2·7 years. All patients received blood transfusion regularly, with a mean duration of blood transfusion of 11·22 ± 3·03 years. Nineteen (38%) children were on DFO chelation therapy, 19 (38%) children were on DEX, and 12 (26%) children were on DFP. The mean duration of chelation therapy was 7·88 ± 2·95 years. Splenectomy was performed in 46% of them. Mean pre-transfusion Hb before the PFT was 8·05 ± 1·31 g dL −1 . A reticular pattern on chest radiograph was present in 38% of the patients. Five patients had oxygen saturations of less than 95%. The control group was 34 (68%) males and 16 (32%) females. Their mean age was13·4 ± 2·7 years. When we performed the PFT, we found that thalassemic children had significantly lower values of all PFT parameters, except for FEV1/FVC% and PEFR% (Table 1) .
Although all the thalassemic children were clinically asymptomatic, 35 (70%) of them had abnormal pulmonary functions. The predominant respiratory impairment in this study was a diffusion defect as all the 35 children with abnormal PFT suffered from diffusion impairment, 17 (34%) of them had 
associated restrictive impairments, and none of the included children showed obstructive impairment. Diffusion impairment was mild in 18 (36%), moderate in 13 (26%) and severe in 4 (8%) of the thalassemic children. Restrictive impairment was mild in nine (18%), moderate in four (8%) and severe in four (8%) of the thalassemic children. Thalassemic children with combined diffusion and restrictive impairment, when compared to those with normal PFT, were significantly older and had significantly longer durations of regular blood transfusions. In addition, they had significantly higher mean serum ferritin levels (P = 0·04) and a significantly higher frequency of serum ferritin above 2500 ng mL −1 (P = 0·005) than thalassemic children with normal PFT results (Table 2) . However, the type of chelation did not demonstrate any statistically significant difference as P = 0·8 (Fig. 1) . We considered a serum ferritin level > 2500 ng mL −1 to be a dangerous threshold as, at that level, the risk of cardiac complications (Olivieri et al., 1994) and liver iron content increase (Karam et al., 2008) .
When we compared the PFT of the thalassemic children above and below the dangerous ferritin threshold, children with -thalassemia major with serum ferritin >2500 ng mL −1 were significantly older (P = 0·01) and had significantly lower values of FVC, FEV1, PEFR, TLC and DLCO (Table 3) .
Severity of diffusion pulmonary impairment only had a significant positive correlation with serum ferritin level. However, the severity of restrictive pulmonary impairment had significant positive correlations with age, duration of blood transfusion and serum ferritin level and a significant negative correlation with duration of chelation (Table 4) .
We found that the only predicting factor for the severity of diffusion impairment in thalassemic children was having a serum ferritin level above the dangerous threshold of >2500 ng mL −1 , as P = 0·02.
Restrictive impairment had many predicting factors, such as being older in age, being on a longer duration of regular blood transfusion, having a shorter duration of chelation and having a serum ferritin above the dangerous threshold, as P = 0·02, 0·03, 0·02 and 0·008, respectively (according to simple logistic regression test). However, the strongest predicting factor for the severity of restrictive ventilation impairment in thalassemic children was having a serum ferritin above the dangerous threshold of >2500 ng mL −1 as P = 0·008 (according to multiple stepwise logistic regression test) (Table 5 ).
DISCUSSION
In our study, we found that thalassemic children, when compared to control group, had significantly lower PFT parameters (P < 0·05) for all except FEV1/FVC% and PEFR%. These results were in accordance with a previous study (Ozyoruk & Misirlioglu, 2015) . However, other studies found all PFT parameters to be significantly lower in thalassemic children, including FEV1/FVC% and PEFR% (Bourli et al., 2012) . Exclusion of thalassemic children with a known history of pulmonary disease in this study, such as asthma, may account for the insignificant affection of FEV1/FVC% and PEFR% as they are affected in cases of obstructive airway disease (Gülhan et al., 2014) .
Thirty-five (70%) thalassemic children had isolated or combined PFT abnormalities. Many studies addressed the pulmonary functions in children with -thalassemia major, reporting percentages of pulmonary dysfunction ranging between 36·1 and 95% (Arora et al., 2001; Abu-Ekteish et al., 2007; Parakh et al., 2007; Rahim et al., 2008; Eidani et al., 2009; Alyasin et al., 2011; Boddu et al., 2015; Ozyoruk & Misirlioglu, 2015) . This wide range of percentages may be attributed to the measurement of lung volumes and diffusion capacities, beside spirometry, in some studies and the use of spirometry alone in others.
Diffusion impairment was the predominant respiratory function abnormality in this study. Numerous studies agreed with us (Li et al., 2002; Khong et al., 2003; Jamal et al., 2005; Parakh et al., 2007; Bourli et al., 2012) . Diffusion impairment may be due to an alveolo-capillary membrane defect leading to a ventilation-perfusion mismatch (Eidani et al., 2009) .
In the present study, a restrictive ventilatory pattern was present in only 16 (32%) of the thalassemic children. Other published studies reported that restrictive abnormalities were the most frequently reported dysfunction (Azarkeivan et al., 2008; Rahim et al., 2008; Sohn et al., 2011; Ozyoruk & Misirlioglu, 2015) . This predominance may be due to the fact that they did not measure lung diffusion capacities (Azarkeivan et al., 2008; Rahim et al., 2008; Ozyoruk & Misirlioglu, 2015) or they targeted adult thalassemic patients in their studies (Sohn et al., 2011) .
The thalassemic children who developed restrictive pulmonary defect, when compared to thalassemic children with normal PFT, were older, had a longer duration of blood transfusion, had higher mean serum ferritin level and had a higher frequency of serum ferritin above the dangerous threshold Children with CDRI (n = 17)
Children with normal PFT (n = 15) p1 p2 p3
Age (years): (mean ± SD) 12·9 ± 2·3 1 4 ·4 ± 2·8 1 2 ·3 ± 2·5 0 ·1 0·6 0·03* Duration of blood transfusion (years): (mean ± SD) 11 ± 2·2 1 2 ·57 ± 3·5 1 0 ·2 ± 2·7 0 ·1 0·4 0·02* Duration of chelation (years): (mean ± SD) 6·7 ± 3·5 7 ·6 ± 5·4 6 ·5 ± 3·3 0 ·5 0·9 0 ·4 Splenectomy: n (%) 10 (55·6%) 9 (52·9%) 8 (53·3%) 0·9 0·9 0 ·9 Pre-transfusion Hb (g dL −1 ) (mean ± SD) 7·2 ± 1·2 7 ± 1 7 ·4 ± 1·3 0 ·8 0·5 0 ·4 Serum ferritin level (ng mL −1 ): (mean ± SD) 3543·2 ± 2292 4660·4 ± 2100 2941 ± 2612 0·2 0·4 0·04* Serum ferritin threshold (>2500 ng mL −1 ): n (%) 9 (50%) 13 (76·5%) 4 (26·7%) 0·1 0·2 0·005* Reticular pattern in CXR: n (%) 6 (33·3%) 8 (47·1%) 5 (33·3%) 0·4 0·99 0·4
CDRI, combined diffusion and restrictive impairment; DI, diffusion impairment; p1: diffusion vs diffusion and restrictive; p2: diffusion vs normal; p3: diffusion and restrictive vs normal. * Statistical significance at P < 0·05. Table 3 . Pulmonary function tests of thalassemic children above and below the dangerous ferritin threshold (>2500 ng mL −1 ) Thalassemic children below dangerous ferritin threshold (≤2500 ng mL −1 ) (n = 24) Thalassemic children above dangerous ferritin threshold (>2500 ng mL −1 ) (n = 26) P value
* Statistical significance at P < 0·05. (>2500 ng mL −1 ). This was in agreement with studies by Sritippayawan et al. (2005) and Bourli et al. (2012) . The type of chelation received did not have a significant effect on PFT in our study, although DFO is known to cause respiratory complication. But these complications were mainly observed when DFO was infused for longer than 24 h in acute iron intoxication incidences (Tenenbein et al., 1992; Atas et al., 2005) . None of our patients received DFO for longer than 12 h per day.
In addition, thalassemic children with serum ferritin levels >2500 ng mL −1 had significantly lower levels of FVC, FEV1, PEFR, TLC and DLCO%. Moreover, serum ferritin correlated positively with severity of diffusion and restrictive pulmonary impairment. Several studies confirmed the correlation between serum ferritin or the body iron burden and pulmonary dysfunctions (Kanj et al., 2000; Carnelli et al., 2003) . However, this contradicted with other studies (Li et al., 2002; Boddu et al., 2015) . The discrepancy of the results among the studies could be due to the multifactorial causes of pulmonary dysfunctions in thalassemic patients. In addition, serum ferritin may be not the most precise marker that reflects iron deposition in tissues. However, it is the most common and least invasive one used for monitoring body iron stores and chelation therapy in thalassemic patients (Hamdy et al., 2007) . Restrictive pulmonary impairment had a significant negative correlation with the duration of chelation as deterioration of lung functions occurs with inadequate chelation (Boddu et al., 2015) . Therefore, difficulties facing chelation therapy should be addressed to maintain normal PFT, such as the availability of chelator drugs, their tolerability, transfusional iron burden and the patient's compliance. All these factors must regularly be reviewed and the chelation modified accordingly (Poggiali et al., 2012) .
Age had a significant positive correlation with the severity of restrictive impairment. Furthermore, it was one of the restrictive impairment predictors. This is consistent with previous studies (Abu-Ekteish et al., 2007; Ozyoruk & Misirlioglu, 2015) . This may be attributed to exaggerated dysynaptic growth beyond the age of 12 years occurring in thalassemia, leading to a disproportionate increase in air spaces than the airway system (Carnelli et al., 2003) . Moreover, restrictive impairment increases with age by protracted transfusion therapy, iron overload (Carnelli et al., 2003) and increasing hepatomegaly (Jamal et al., 2005) .
The only predictor for diffusion pulmonary impairment in this study was a serum ferritin level above the threshold of 2500 ng mL −1 . On the other hand, restrictive pulmonary impairment could be predicted by many parameters such as being older in age, having a longer duration of blood transfusion, having a shorter duration of chelation and having a serum ferritin level above the threshold of 2500 ng mL −1 , whereas the strongest predicting factor for the restrictive dysfunction in this study was having a serum ferritin level above the threshold of 2500 ng mL −1 .
CONCLUSION
From the study, we can conclude that, although the thalassemic children were all clinically asymptomatic, 70% of them had pulmonary function abnormalities. Diffusion impairment was the predominant pulmonary dysfunction in children with transfusion-dependent beta thalassemia in this study. The severity of pulmonary dysfunctions had positive correlations with body iron stores measured by serum ferritin. Moreover, having a serum ferritin above the dangerous threshold was the only predicting factor for diffusion impairment and the strongest predicting factor for restrictive dysfunction. This study has several limitations; for example, it would be more ideal to assess iron overload through hepatic iron content by biopsy or magnetic resonance imaging (MRI). However, serum ferritin is routinely used to assess iron overload in Egyptian thalassemia patients as it is less invasive than biopsy and cheaper and more available than MRI. In addition, following up these patients and assessing longitudinal changes of their lung function would be more instructive.
